Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy

Radiology and Oncology

Lainscak Mitja¹  Omersa Daniel²  Cufer Tanja³  Marcun Robert³ 

[1] Faculty of Medicine, Ljubljana, Slovenia;National Institute of Public Health, Ljubljana, Slovenia;University Clinic Golnik, Golnik, Slovenia;

关键词: cardiotoxicity;    platinum-based chemotherapy;    lung cancer;    cardiac biomarkers;   

DOI  :  10.1515/raon-2016-0037

来源: DOAJ

【 摘 要 】

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains an important cause of cancer death worldwide. Platinum-based chemotherapy (PBC) for NSCLC can modify outcome while the risk of cardiotoxicity remains poorly researched. We aimed to evaluate the incidence and severity of cardiac injury during PBC in patients with NSCLC and to identify patients at risk.

【 授权许可】

Unknown